NCT00532467View on ClinicalTrials.gov

Multiple Dose Safety Study of SRX251 Capsules in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Healthy
Interventions
DRUG

SRX251

Trial Locations (1)

07601

Advanced Biomedical Research, Inc., Hackensack

Sponsors
All Listed Sponsors
lead

Azevan Pharmaceuticals

INDUSTRY

NCT00532467 - Multiple Dose Safety Study of SRX251 Capsules in Healthy Volunteers | Biotech Hunter | Biotech Hunter